|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4152 | |
| A61K 47/02 | |||
| A61K 9/08 | |||
| A61P 25/00 | |||
| A61K 9/00 |
| (11) | Number of the document | 3551181 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18701303.2 |
| Date of filing the European patent application | 2018-01-17 | |
| (97) | Date of publication of the European application | 2019-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/051097 |
| Date | 2018-01-17 |
| (87) | Number | WO 2018/134243 |
| Date | 2018-07-26 |
| (30) | Number | Date | Country code |
| 17151741 | 2017-01-17 | EP | |
| 17180087 | 2017-07-06 | EP | |
| PCT/EP2017/0670 | 2017-07-06 | WO |
| (72) |
MOOLENAAR, Sytske Hyke, NL
VAN DER GEEST, Ronald, NL
|
| (73) |
Treeway TW001 B.V.,
Sevillaweg 142, 3047 AL Rotterdam,
NL
|
| (54) | TREATMENT COMPRISING ORAL OR GASTRIC ADMINISTRATION OF EDARAVONE |
| TREATMENT COMPRISING ORAL OR GASTRIC ADMINISTRATION OF EDARAVONE |